Stoke Therapeutics, Inc. (STOK)
34.20
+0.05
(+0.15%)
USD |
NASDAQ |
Dec 11, 12:29
Stoke Therapeutics Research and Development Expense (Quarterly): 37.25M for Sept. 30, 2025
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Biogen, Inc. | 369.60M |
| Janux Therapeutics, Inc. | 34.63M |
| Insmed, Inc. | 186.42M |
| Sarepta Therapeutics, Inc. | 218.89M |
| Aldeyra Therapeutics, Inc. | 5.431M |